Trials / Recruiting
RecruitingNCT05741593
Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 65 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.
Detailed description
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. The probability of stroke recurrence is high: about 25% the first year , and 30 to 40% in the 5 years following the stroke. Recurrent strokes are responsible for significant disability, institutionalization, major neurocognitive disorders, and death. In order to reduce the risk of stroke recurrence, multiple secondary prevention strategies have demonstrated their effectiveness, such as the prescription of drugs (in particular statins and antithrombotics), the establishment of a balanced diet, the practice of an activity physical, or even tobacco addiction. However, the effectiveness of these strategies is optimal if and only if patients adhere to them. In addition, previous studies have focused on the brakes and levers of medication adherence in the context of secondary prevention treatment in stroke. In elderly patients, other obstacles could have been identified by specific studies, such as cognitive, sensory, functional disorders or even isolation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Analysis of the verbatim from the transcription of the recorded interviews. | recorded semi-structured interviews between the patients and the pharmacist |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2023-02-23
- Last updated
- 2024-11-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05741593. Inclusion in this directory is not an endorsement.